Priscila Gomes Pereira

Dr. Priscila Gomes Pereira

Universidade Estadual do Rio de Janeiro - UERJ, Rio de Janeiro, Brazil
orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2022 in Journal of Endocrinology and Metabolism
Verified
Journal Article
Open access
PDF file
ISIsaias dos Santos Silva
Isaias dos Santos Silva
LSLuciano Pinto Souza
Luciano Pinto Souza
Priscila Gomes PereiraPriscila Gomes Pereira
Priscila Gomes Pereira
JCJorge José Carvalho
Jorge José Carvalho
AMAdalgiza Mafra Moreno
Adalgiza Mafra Moreno
ACAluana Santana Carlos
Aluana Santana Carlos
Combination of a Glucagon-Like Peptide 1 Analog and a Sodium-Glucose Cotransporter 2 Inhibitor Improves Lipid Metabolism Compared to the Monotherapies in Experimental Metabolic Syndrome

1 January 2018 in Evidence-Based Complementary and Alternative Medicine
Verified
Journal Article
Open access
PDF file
PMPolyana C Marinho
Polyana C Marinho
AVAline B Vieira
Aline B Vieira
Priscila Gomes PereiraPriscila Gomes Pereira
Priscila Gomes Pereira
Kíssila RabeloKíssila Rabelo
Kíssila Rabelo
BCBianca T Ciambarella
Bianca T Ciambarella
JCJorge José Carvalho
Jorge José Carvalho
Nonalcoholic fatty liver disease (NAFLD) is recognized as the most common cause of liver dysfunction worldwide and is commonly associated with obesity. Evidences suggest that NAFLD might be a mitochondrial disease, which contributes to the hepatic steatosis, oxidative stress, cytokine release, and cell death. Capybara oil (CO) is a rich source of polyunsaturated fatty acids (PUFA), which is known to improve inflammation and oxidative stress. In order to determine the effects of CO on NAFLD, C57Bl/6 mice were divided into 3 groups and fed a high‐fat diet (HFD) (NAFLD group and NAFLD + CO group) or a control diet (CG group) during 16 weeks. The CO (1.5 g/kg/daily) was administered by gavage during the last 4 weeks of the diet protocol. We evaluated plasma liver enzymes, hepatic steatosis, and cytokine expression in liver as well as hepatocyte ultrastructural morphology and mitochondrial function. CO treatment suppressed hepatic steatosis, attenuated inflammatory response, and decreased plasma alanine aminotransferase (ALT) in mice with NAFLD. CO was also capable of restoring mitochondrial ultrastructure and function as well as balance superoxide dismutase and catalase levels. Our findings indicate that CO treatment has positive effects on NAFLD improving mitochondrial dysfunction, steatosis, acute inflammation, and oxidative stress.

28 June 2023 in Nutrients
Verified
Journal Article
Open access
PDF file
Priscila Gomes PereiraPriscila Gomes Pereira
Priscila Gomes Pereira
Luciana Lontro AlvesLuciana Lontro Alves
Luciana Lontro Alves
BCBianca Ciambarella
Bianca Ciambarella
Kíssila RabeloKíssila Rabelo
Kíssila Rabelo
ANAna Lúcia R. Nascimento
Ana Lúcia R. Nascimento
JCJorge José Carvalho
Jorge José Carvalho
Obesity is an inflammatory disease associated with secondary diseases such as kidney disease, which can cause lipotoxicity, inflammation and loss of organ function. Polyunsaturated fatty acids act in the production of lipid mediators and have anti-inflammatory characteristics. In this work, the objective was to evaluate renal histopathology in obese mice and the effects of treatment with capybara oil (CO) (5000 mg/kg/day for 4 weeks). Parameters such as body mass, lipid profile, systolic blood pressure, urinary creatinine and protein excretion, structure and ultrastructure of the renal cortex, fibrosis, tissue inflammation and oxidative stress were analyzed. CO treatment in obese mice showed improvement in the lipid profile and reduction in systolic blood pressure levels, in addition to beneficial remodeling of the renal cortex. Our data demonstrated that CO decreased inflammation, oxidative stress and renal fibrosis, as evidenced by quantifying the expression of TNF-α, IL-10, CAT, SOD, α-SMA and TGF-β. Although treatment with CO did not show improvement in renal function, ultrastructural analysis showed that the treatment was effective in restoring podocytes and pedicels, with restructuring of the glomerular filtration barrier. These results demonstrate, for the first time, that treatment with CO is effective in reducing kidney damage, being considered a promising treatment for obesity.

1 January 2024 in Journal of Obesity
Verified
Journal Article
Open access
PDF file
Luciana Lontro AlvesLuciana Lontro Alves
Luciana Lontro Alves
Priscila Gomes PereiraPriscila Gomes Pereira
Priscila Gomes Pereira
BCBianca Ciambarella
Bianca Ciambarella
MCMiguel Porto Campos
Miguel Porto Campos
Kíssila RabeloKíssila Rabelo
Kíssila Rabelo
JCJorge José Carvalho
Jorge José Carvalho
Obesity is a complex chronic disease characterized by excess body fat (adipose) that is harmful to health and has been a major global health problem. It may be associated with several diseases, such as nonalcoholic fatty liver disease (NAFLD). Polyunsaturated fatty acids (PUFA) are lipid mediators that have anti‐inflammatory characteristics and can be found in animals and plants, with capybara oil (CO) being a promising source. So, we intend to evaluate the hepatic pathophysiological alterations in C57Bl/6 mice with NAFLD, caused by obesity, and the possible beneficial effects of OC in the treatment of this disease. Eighteen 3‐month‐old male C57Bl/6 mice received a control or high‐fat diet for 18 weeks. From the 15th to the 18th week, the animals received treatment—through orogastric gavage—with placebo or free capybara oil (5 g/kg). Parameters inherent to body mass, glucose tolerance, evaluation of liver enzymes, percentage of hepatic steatosis, oxidative stress, the process of cell death with the apoptotic biomarkers (Bax, Bcl2, and Cytochrome C), and the ultrastructure of hepatocytes were analyzed. Even though the treatment with CO was not able to disassemble the effects on the physiological parameters, it proved to be beneficial in reversing the morphological and ultrastructural damage present in the hepatocytes. Thus, demonstrating that CO has beneficial effects in reducing steatosis and the apoptotic pathway, it is a promising treatment for NAFLD.